bioRxiv · 10.1101/2021.12.08.471715
STRAIGHT-IN: A platform for high-throughput targeting of large DNA payloads into human pluripotent stem cells
Abstract
Inserting large DNA payloads (>10 kb) into specific genomic sites of mammalian cells remains challenging. Applications ranging from synthetic biology to evaluating the pathogenicity of disease-associated variants for precision medicine initiatives would greatly benefit from tools that facilitate this process. Here, we merge the strengths of different classes of site-specific recombinases and combine these with CRISPR/Cas9-mediated homologous recombination to develop a strategy for stringent site-specific replacement of genomic fragments at least 50 kb in size in human induced pluripotent stem cells (hiPSCs). We demonstrate the versatility of STRAIGHT-IN (Serine and Tyrosine Recombinase Assisted Integration of Genes for High-Throughput INvestigation) by: (i) inserting various combinations of fluorescent reporters into hiPSCs to assess excitation-contraction coupling cascade in derivative cardiomyocytes, and; (ii) simultaneously targeting multiple variants associated with inherited cardiac arrhythmic disorder into a pool of hiPSCs. STRAIGHT-IN offers a precise approach to generate genetically-matched panels of hiPSC lines efficiently and cost-effectively.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Grandela, C., Blanch-Asensio, A., Brandao, K. O., de Korte, T., Yiangou, L., Mol, M. P. H., van Meer, B. J., Mummery, C. L., Davis, R. P.. 2021-12-09. STRAIGHT-IN: A platform for high-throughput targeting of large DNA payloads into human pluripotent stem cells. https://doi.org/10.1101/2021.12.08.471715
Cite the original work for its findings. Save a collection to share your selection of sources.